IL146564A0 - Phenoxypropylamine derivatives and pharmaceutical compositions containing the same - Google Patents
Phenoxypropylamine derivatives and pharmaceutical compositions containing the sameInfo
- Publication number
- IL146564A0 IL146564A0 IL14656400A IL14656400A IL146564A0 IL 146564 A0 IL146564 A0 IL 146564A0 IL 14656400 A IL14656400 A IL 14656400A IL 14656400 A IL14656400 A IL 14656400A IL 146564 A0 IL146564 A0 IL 146564A0
- Authority
- IL
- Israel
- Prior art keywords
- same
- pharmaceutical compositions
- compositions containing
- phenoxypropylamine
- phenoxypropylamine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14275099 | 1999-05-24 | ||
JP16616099 | 1999-06-14 | ||
JP27738499 | 1999-09-29 | ||
JP2000018080 | 2000-01-25 | ||
PCT/JP2000/003279 WO2000071517A1 (fr) | 1999-05-24 | 2000-05-22 | Compose de phenoxypropylamine |
Publications (1)
Publication Number | Publication Date |
---|---|
IL146564A0 true IL146564A0 (en) | 2002-07-25 |
Family
ID=27472476
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14656400A IL146564A0 (en) | 1999-05-24 | 2000-05-22 | Phenoxypropylamine derivatives and pharmaceutical compositions containing the same |
IL146564A IL146564A (en) | 1999-05-24 | 2001-11-19 | History of phoenixypropylamine and the pharmaceutical preparations containing them |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL146564A IL146564A (en) | 1999-05-24 | 2001-11-19 | History of phoenixypropylamine and the pharmaceutical preparations containing them |
Country Status (17)
Country | Link |
---|---|
US (2) | US6720320B2 (fr) |
EP (1) | EP1188747B1 (fr) |
JP (1) | JP3893878B2 (fr) |
KR (2) | KR100799134B1 (fr) |
CN (1) | CN1164574C (fr) |
AT (1) | ATE303987T1 (fr) |
AU (1) | AU777594B2 (fr) |
BR (1) | BR0011542A (fr) |
CA (2) | CA2716369C (fr) |
DE (1) | DE60022504T2 (fr) |
DK (1) | DK1188747T3 (fr) |
EA (1) | EA004704B1 (fr) |
ES (1) | ES2244438T3 (fr) |
IL (2) | IL146564A0 (fr) |
MX (1) | MXPA01012046A (fr) |
NZ (1) | NZ516111A (fr) |
WO (1) | WO2000071517A1 (fr) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6844344B2 (en) * | 1999-12-20 | 2005-01-18 | Eli Lilly And Company | Benzofuran derivatives |
EP1242411B1 (fr) | 1999-12-20 | 2006-03-08 | Eli Lilly And Company | Derives de l'indole destines au traitement de depression et d'anxiete |
AU2002224105A1 (en) * | 2000-11-27 | 2002-06-03 | Mitsubishi Pharma Corporation | Piperidine compounds and medicinal use thereof |
CA2500115A1 (fr) * | 2002-09-26 | 2004-04-08 | Warner-Lambert Company Llc | Piperazines substituees heterocycliques destinees au traitement de la schizophrenie |
SE0303280D0 (sv) * | 2003-12-05 | 2003-12-05 | Astrazeneca Ab | Novel compounds |
CA2548447A1 (fr) * | 2003-12-08 | 2005-06-23 | Warner-Lambert Company Llc | Derives d'indane heterocyclique substitue et composes apparentes pour le traitement de la schizophrenie |
GB0407025D0 (en) * | 2004-03-29 | 2004-04-28 | Glaxo Group Ltd | Novel compounds |
US7674822B2 (en) | 2004-11-24 | 2010-03-09 | Wyeth | PTP1b inhibitors |
WO2006101454A1 (fr) * | 2005-03-21 | 2006-09-28 | S*Bio Pte Ltd | Derives du benzothiophene: preparation et applications pharmaceutiques |
TWI320783B (en) | 2005-04-14 | 2010-02-21 | Otsuka Pharma Co Ltd | Heterocyclic compound |
US8034953B2 (en) | 2005-05-10 | 2011-10-11 | Incyte Corporation | Modulators of indoleamine 2,3-dioxygenase and methods of using the same |
TWI329641B (en) | 2005-08-31 | 2010-09-01 | Otsuka Pharma Co Ltd | (benzo[b]thiophen-4-yl)piperazine compounds, pharmaceutical compositions comprising the same, uses of the same and processes for preparing the same |
WO2007065655A1 (fr) * | 2005-12-07 | 2007-06-14 | Neurosearch Sweden Ab | Phenylpiperidines disubstituees utiles en tant que modulateurs de la neurotransmission catecholaminergique corticale |
ES2540561T3 (es) | 2005-12-20 | 2015-07-10 | Incyte Corporation | N-hidroxiamidinoheterociclos como moduladores de indolamina 2,3-dioxigenasa |
AU2006335108B2 (en) | 2005-12-30 | 2011-04-07 | Merck Sharp & Dohme Corp. | CETP inhibitors |
US9249407B2 (en) | 2006-02-03 | 2016-02-02 | Opko Biologics Ltd. | Long-acting coagulation factors and methods of producing same |
US7649098B2 (en) * | 2006-02-24 | 2010-01-19 | Lexicon Pharmaceuticals, Inc. | Imidazole-based compounds, compositions comprising them and methods of their use |
CL2007002650A1 (es) | 2006-09-19 | 2008-02-08 | Incyte Corp | Compuestos derivados de heterociclo n-hidroxiamino; composicion farmaceutica, util para tratar cancer, infecciones virales y desordenes neurodegenerativos entre otras. |
JP5319532B2 (ja) | 2006-09-19 | 2013-10-16 | インサイト・コーポレイション | インドールアミン2,3−ジオキシゲナーゼのモジュレーターとしてのn−ヒドロキシアミジノヘテロサイクル |
JP2008195654A (ja) * | 2007-02-14 | 2008-08-28 | Mitsubishi Tanabe Pharma Corp | ベンゾ[b]フラン化合物の新規結晶形 |
US20090270496A1 (en) * | 2007-05-03 | 2009-10-29 | Courchesne William E | Antifungal compounds |
TW200920355A (en) * | 2007-09-06 | 2009-05-16 | Lexicon Pharmaceuticals Inc | Compositions and methods for treating immunological and inflammatory diseases and disorders |
IE20070928A1 (en) * | 2007-12-21 | 2009-09-30 | Giuliani Int Ltd | Multi target ligands |
RS53688B9 (sr) | 2008-07-08 | 2020-01-31 | Incyte Holdings Corp | 1,2,5-oksadiazoli kao inhibitori indoleamin 2,3-dioksigenaze |
CN102405212B (zh) | 2009-02-18 | 2016-01-27 | 康奈尔大学 | 在体内外使用的偶联识别/检测系统 |
US8324250B2 (en) | 2009-03-19 | 2012-12-04 | Hoffmann-La Roche Inc. | Piperidine derivatives as NK3 receptor antagonists |
WO2011022679A2 (fr) * | 2009-08-20 | 2011-02-24 | University Of Tennessee Research Foundation, The | Composés cannabinoïdes benzofurane et méthodes dutilisation associées |
WO2013016694A2 (fr) | 2011-07-27 | 2013-01-31 | Cornell University | Procédé pour la détection et la quantification d'arn |
AU2014209200B2 (en) * | 2013-01-24 | 2018-11-01 | Minerva Neurosciences, Inc. | Use of phenoxypropylamine compounds to treat depression |
PT3030561T (pt) | 2013-08-07 | 2017-03-23 | Cadila Healthcare Ltd | N-cianometilamidas como inibidores de cinase janus |
US9664676B2 (en) | 2013-09-06 | 2017-05-30 | Cornell University | RNA sequences that induce fluorescence of small molecule fluorophores |
US20150158926A1 (en) | 2013-10-21 | 2015-06-11 | Opko Biologics, Ltd. | Long-acting polypeptides and methods of producing and administering same |
ES2799582T3 (es) | 2013-11-08 | 2020-12-18 | Incyte Holdings Corp | Proceso para la síntesis de un inhibidor de indoleamina 2,3-dioxigenasa |
RU2719446C2 (ru) * | 2014-11-03 | 2020-04-17 | Айомет Фарма Лтд | Фармацевтическое соединение |
WO2016192657A1 (fr) | 2015-06-03 | 2016-12-08 | Sunshine Lake Pharma Co., Ltd. | Composés de pipérazine substitués, leurs procédés d'utilisation et leurs utilisations |
US10960058B2 (en) | 2015-06-19 | 2021-03-30 | Opko Biologics Ltd. | Long-acting coagulation factors and methods of producing same |
JP2019516758A (ja) | 2016-05-25 | 2019-06-20 | 田辺三菱製薬株式会社 | 不安障害を治療するための(2S)−1−[4−(3,4−ジクロロフェニル)ピペリジン−1−イル]−3−[2−(5−メチル−1,3,4−オキサジアゾール−2−イル)ベンゾ[b]フラン−4−イルオキシ]プロパン−2−オールまたはその代謝産物 |
TW201808988A (zh) | 2016-07-11 | 2018-03-16 | 歐科生物製品有限公司 | 長效型凝血因子及其生產方法 |
JP7439096B2 (ja) * | 2018-09-04 | 2024-02-27 | 田辺三菱製薬株式会社 | 疼痛を処置するためにフェノキシプロピルアミン化合物を使用する方法 |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2042054A1 (de) * | 1970-08-25 | 1972-03-02 | Agfa Gevaert Ag | Photographisches Trockenkopierverfahren |
DE2106577C2 (de) * | 1971-02-11 | 1982-07-08 | Agfa-Gevaert Ag, 5090 Leverkusen | Aufzeichnungsmaterial für das photographische Trockenkopierverfahren und photographisches Verfahren zur Herstellung von Bildern |
JPS4718538U (fr) | 1971-03-31 | 1972-11-01 | ||
DE2337461A1 (de) * | 1973-07-24 | 1975-02-06 | Boehringer Mannheim Gmbh | Neue indolderivate und verfahren zu deren herstellung |
JPS5290307A (en) | 1976-01-26 | 1977-07-29 | Canon Kk | Thermoodeveloping photoosensitive material for electrostatic printing master |
DE2702919A1 (de) * | 1976-01-26 | 1977-07-28 | Canon Kk | Durch erwaermung entwickelbares, lichtempfindliches aufzeichnungsmaterial |
JPS5292610A (en) | 1976-01-26 | 1977-08-04 | Canon Kk | Electrostatic printing master |
US4191765A (en) * | 1976-05-25 | 1980-03-04 | Hoechst Aktiengesellschaft | 1-Aryloxy-2-hydroxy-3-aminopropanes |
DE2623314C2 (de) | 1976-05-25 | 1984-08-02 | Hoechst Ag, 6230 Frankfurt | 1-Aryloxy-2-Hydroxy-3-aminopropane, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
WO1980000152A1 (fr) * | 1978-07-03 | 1980-02-07 | Sandoz Ag | Derives d'un 3-aminopropoxy-aryle, leur preparation et utilisation |
JPS55100361A (en) | 1979-01-18 | 1980-07-31 | Sandoz Ag | 33aminopropoxyaryl derivative |
JPS58121214A (ja) * | 1982-01-09 | 1983-07-19 | Kanegafuchi Chem Ind Co Ltd | 血小板凝集阻害剤 |
JPS60202872A (ja) * | 1984-03-27 | 1985-10-14 | Kaken Pharmaceut Co Ltd | ベンゾフラン誘導体、その製法およびそれを有効成分とする降圧剤 |
DE3427985A1 (de) * | 1984-07-28 | 1986-01-30 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue 2h-l-benzopyran-2-on-derivate, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten |
JPS6157572A (ja) * | 1984-08-28 | 1986-03-24 | Kanegafuchi Chem Ind Co Ltd | 新規α−ベンジリデン−γ−ブチロラクトン誘導体 |
JPS61218582A (ja) * | 1985-03-23 | 1986-09-29 | Kaken Pharmaceut Co Ltd | ベンゾフラン誘導体、その製法およびそれを有効成分とする降圧剤 |
HU209759B (en) * | 1986-07-17 | 1994-10-28 | Hem Res Inc | Method for the preparation of synergistic pharmaceutical composition containing lymphokines and mismatched double-stranded rnas |
US4861897A (en) * | 1987-06-22 | 1989-08-29 | Ortho Pharmaceutical Corporation | 2-Aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles |
HU209753B (en) | 1990-12-13 | 1995-02-28 | Richter Gedeon Vegyeszeti Gyar Rt. | Process for producing of 3-(4-nitrophenoxy)-propylamine derivatives and pharmaceutical compositions comprising them |
JPH06506937A (ja) * | 1991-04-09 | 1994-08-04 | ジ・アップジョン・カンパニー | 多剤耐性細胞に感受性を付与するアミンの使用 |
US5281624A (en) | 1991-09-27 | 1994-01-25 | Eli Lilly And Company | N-alkyl-3-phenyl-3-(2-substituted phenoxy) propylamines and pharmaceutical use thereof |
DE69425882T2 (de) | 1993-03-29 | 2001-01-11 | Basf Ag | 1-amino-3-phenoxy-propan-derivate als modulatoren bei multi-drug resistenz |
EP0620222A3 (fr) | 1993-04-14 | 1995-04-12 | Lilly Co Eli | Tétrahydro-bêta-carbolines. |
US5500431A (en) * | 1993-04-14 | 1996-03-19 | Eli Lilly And Company | Tetrahydro-β-carbolines |
JPH0717952A (ja) * | 1993-06-29 | 1995-01-20 | Nissan Chem Ind Ltd | ベンジリデン誘導体 |
WO1995024200A1 (fr) * | 1994-03-11 | 1995-09-14 | Eli Lilly And Company | Methode de traitement d'etats associes au recepteur 5ht¿2b? |
US5789402A (en) | 1995-01-17 | 1998-08-04 | Eli Lilly Company | Compounds having effects on serotonin-related systems |
US5576321A (en) * | 1995-01-17 | 1996-11-19 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
JPH09136877A (ja) | 1995-06-16 | 1997-05-27 | Takeda Chem Ind Ltd | 複素環化合物、その製造法及び用途 |
US5912256A (en) * | 1996-06-20 | 1999-06-15 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
ES2176877T3 (es) * | 1997-09-26 | 2002-12-01 | Kowa Co | Derivados de tetrazol como antagonistas de ltd4 y h1. |
JP4246822B2 (ja) | 1997-09-26 | 2009-04-02 | 興和株式会社 | テトラゾール誘導体 |
CN1155567C (zh) * | 1998-04-29 | 2004-06-30 | 惠氏公司 | 抑制精神的吲哚基衍生物 |
JP2000086603A (ja) * | 1998-07-15 | 2000-03-28 | Yoshitomi Pharmaceut Ind Ltd | 桂皮酸アミド誘導体および3―フェニルプロピオン酸アミド誘導体 |
BR9916318A (pt) * | 1998-12-18 | 2001-08-14 | Basilea Pharmaceutica Ag | Compostos bicìclicos |
AU2002224105A1 (en) * | 2000-11-27 | 2002-06-03 | Mitsubishi Pharma Corporation | Piperidine compounds and medicinal use thereof |
-
2000
- 2000-05-22 KR KR1020017015024A patent/KR100799134B1/ko active IP Right Grant
- 2000-05-22 KR KR1020077026625A patent/KR100882544B1/ko active IP Right Grant
- 2000-05-22 DK DK00927844T patent/DK1188747T3/da active
- 2000-05-22 CN CNB008086044A patent/CN1164574C/zh not_active Expired - Lifetime
- 2000-05-22 AT AT00927844T patent/ATE303987T1/de not_active IP Right Cessation
- 2000-05-22 EP EP00927844A patent/EP1188747B1/fr not_active Expired - Lifetime
- 2000-05-22 JP JP2000619774A patent/JP3893878B2/ja not_active Expired - Lifetime
- 2000-05-22 CA CA2716369A patent/CA2716369C/fr not_active Expired - Lifetime
- 2000-05-22 ES ES00927844T patent/ES2244438T3/es not_active Expired - Lifetime
- 2000-05-22 DE DE60022504T patent/DE60022504T2/de not_active Expired - Lifetime
- 2000-05-22 CA CA2375008A patent/CA2375008C/fr not_active Expired - Lifetime
- 2000-05-22 MX MXPA01012046A patent/MXPA01012046A/es active IP Right Grant
- 2000-05-22 AU AU46160/00A patent/AU777594B2/en not_active Ceased
- 2000-05-22 IL IL14656400A patent/IL146564A0/xx not_active IP Right Cessation
- 2000-05-22 BR BR0011542-8A patent/BR0011542A/pt not_active IP Right Cessation
- 2000-05-22 EA EA200101232A patent/EA004704B1/ru not_active IP Right Cessation
- 2000-05-22 NZ NZ516111A patent/NZ516111A/en unknown
- 2000-05-22 WO PCT/JP2000/003279 patent/WO2000071517A1/fr active IP Right Grant
-
2001
- 2001-11-19 IL IL146564A patent/IL146564A/en unknown
- 2001-11-23 US US09/990,389 patent/US6720320B2/en not_active Expired - Lifetime
-
2003
- 2003-12-22 US US10/740,418 patent/US7196199B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DK1188747T3 (da) | 2006-01-23 |
ES2244438T3 (es) | 2005-12-16 |
EA200101232A1 (ru) | 2002-06-27 |
JP3893878B2 (ja) | 2007-03-14 |
CA2375008A1 (fr) | 2000-11-30 |
CA2716369C (fr) | 2013-05-14 |
ATE303987T1 (de) | 2005-09-15 |
EP1188747A4 (fr) | 2002-10-09 |
EP1188747B1 (fr) | 2005-09-07 |
WO2000071517A1 (fr) | 2000-11-30 |
US6720320B2 (en) | 2004-04-13 |
KR20020012235A (ko) | 2002-02-15 |
KR100882544B1 (ko) | 2009-02-12 |
MXPA01012046A (es) | 2003-09-04 |
US7196199B2 (en) | 2007-03-27 |
CN1164574C (zh) | 2004-09-01 |
US20020111358A1 (en) | 2002-08-15 |
AU777594B2 (en) | 2004-10-21 |
KR20070118193A (ko) | 2007-12-13 |
CN1378533A (zh) | 2002-11-06 |
CA2375008C (fr) | 2011-01-04 |
CA2716369A1 (fr) | 2000-11-30 |
KR100799134B1 (ko) | 2008-01-29 |
EA004704B1 (ru) | 2004-06-24 |
NZ516111A (en) | 2003-05-30 |
US20040138227A1 (en) | 2004-07-15 |
DE60022504D1 (de) | 2005-10-13 |
IL146564A (en) | 2006-12-31 |
BR0011542A (pt) | 2002-03-05 |
AU4616000A (en) | 2000-12-12 |
EP1188747A1 (fr) | 2002-03-20 |
DE60022504T2 (de) | 2006-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL146564A0 (en) | Phenoxypropylamine derivatives and pharmaceutical compositions containing the same | |
MA27040A1 (fr) | Nucleosides substitues en 4' | |
BR0200782A (pt) | Compostos para o tratamento da isquemia | |
RS53428B (en) | COMPOSITIONS AND ANTI-VIRUS ACTIVITY OF SUBSTITUTED AZAINDOLOXOSCETER PIPERAZINE DERIVATIVES | |
MXPA05012247A (es) | Derivados de bencimidazol nuevos. | |
ATE300541T1 (de) | Pyrazolopyridinderivate | |
WO2004014389A8 (fr) | Inhibiteurs de metalloproteases matrices a base de derives de 3,4-dihydroquinoline-2-one, d'oxazine-3-one fusionnee en 5,6, et de thiazine-3-one fusionnee en 5,6 | |
WO2004067703A3 (fr) | Antagonistes 5ht7 et agonistes inverses | |
ATE253359T1 (de) | Antithrombotische mittel | |
DE60002583D1 (de) | Benzofurylpiperazine als serotonin-agonisten | |
DE60316436D1 (de) | Amidderivate als inhibitoren der enzymatischen aktivität von renin | |
NO983444D0 (no) | Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer | |
ATE274515T1 (de) | Pyrazolopyridinderivate | |
WO2004056832A3 (fr) | Derives d'epothilone | |
AU2002357740A1 (en) | Pyrazolo-pyridine derivatives as antiherpes agents | |
DE69828522D1 (de) | Antithrombotische mittel | |
WO2004048381A3 (fr) | Nouveaux composes de pyrazoloazepine utilises en tant qu'agents pharmaceutiques | |
EP1241165A4 (fr) | Derives de chromane et de thiochromane optiquement actifs | |
WO2004065360A3 (fr) | Nouveaux derives de piperazine et leur utilisation comme intermediaires de synthese | |
MXPA05006587A (es) | Compuestos de tiazol como derivados de antagonistas del receptor de la integrina. | |
AU2003294405A1 (en) | Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol | |
DE602004009306D1 (de) | 3,4-dihydro-1h-chinolin-2-onderivate als norepinephrin-wiederaufnahme-hemmern | |
CO5690574A2 (es) | Nuevos compuestos derivados de indolina como inhibidores de la colesterol-actiltransferasa (acat) y uso medico del mismo | |
AU1434201A (en) | Antithrombotic agents | |
EP1241166A4 (fr) | Derives de 3-methyl-chromane et -thiochromane |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
MM9K | Patent not in force due to non-payment of renewal fees |